Hemoglobin decline, function, and mortality in the elderly

The cardiovascular health study

Neil A. Zakai, Benjamin French, Alice M. Arnold, Anne B. Newman, Linda F. Fried, John Robbins, Paulo Chaves, Mary Cushman

Research output: Contribution to journalArticle

Abstract

While anemia is associated with poor functional and mortality outcomes in the elderly, the impact of hemoglobin decline is less studied. We evaluated the determinants and consequences of hemoglobin decline in 3,758 non-anemic participants from the Cardiovascular Health Study, a prospective cohort of community-dwelling elderly ≥65 years old at baseline and followed for up to 16 years. Hemoglobin was measured at baseline and 3 years later and anemia defined by World Health Organization (WHO) criteria. We modeled hemoglobin decline in two ways: (1) per each 1 g/dL decrease in hemoglobin and (2) development of anemia by the WHO criteria. Among participants without baseline anemia, hemoglobin decreased by 0.4 g/dL and 9% developed anemia over 3 years. Baseline increasing age, female sex, diabetes, and kidney disease predicted hemoglobin decline over 3 years. Baseline increasing age, being African-American, and kidney disease predicted anemia development over 3 years. Hemoglobin decline was associated with subsequent worse cognitive function in men and anemia development with subsequent worse cognitive function in women. Both anemia development (HR 1.39, 95% CI 1.15, 1.69) and hemoglobin decline (HR 1.11, 95% CI 1.04, 1.18 per 1 g/dL decrease) predicted subsequent mortality in men and women. Hemoglobin decreases identified a large group of elderly individuals at risk for subsequent adverse outcomes who would not be identified using the WHO anemia criteria. These data may allow clinicians to identify at-risk elderly individuals for early intervention to improve the quality and quantity of life.

Original languageEnglish (US)
Pages (from-to)5-9
Number of pages5
JournalAmerican Journal of Hematology
Volume88
Issue number1
DOIs
StatePublished - Jan 2013

Fingerprint

Hemoglobins
Anemia
Mortality
Health
Kidney Diseases
Cognition
Independent Living
African Americans
Quality of Life
Prospective Studies

ASJC Scopus subject areas

  • Hematology

Cite this

Zakai, N. A., French, B., Arnold, A. M., Newman, A. B., Fried, L. F., Robbins, J., ... Cushman, M. (2013). Hemoglobin decline, function, and mortality in the elderly: The cardiovascular health study. American Journal of Hematology, 88(1), 5-9. https://doi.org/10.1002/ajh.23336

Hemoglobin decline, function, and mortality in the elderly : The cardiovascular health study. / Zakai, Neil A.; French, Benjamin; Arnold, Alice M.; Newman, Anne B.; Fried, Linda F.; Robbins, John; Chaves, Paulo; Cushman, Mary.

In: American Journal of Hematology, Vol. 88, No. 1, 01.2013, p. 5-9.

Research output: Contribution to journalArticle

Zakai, NA, French, B, Arnold, AM, Newman, AB, Fried, LF, Robbins, J, Chaves, P & Cushman, M 2013, 'Hemoglobin decline, function, and mortality in the elderly: The cardiovascular health study', American Journal of Hematology, vol. 88, no. 1, pp. 5-9. https://doi.org/10.1002/ajh.23336
Zakai, Neil A. ; French, Benjamin ; Arnold, Alice M. ; Newman, Anne B. ; Fried, Linda F. ; Robbins, John ; Chaves, Paulo ; Cushman, Mary. / Hemoglobin decline, function, and mortality in the elderly : The cardiovascular health study. In: American Journal of Hematology. 2013 ; Vol. 88, No. 1. pp. 5-9.
@article{c689eb67b1294709b28543ca8f2475c0,
title = "Hemoglobin decline, function, and mortality in the elderly: The cardiovascular health study",
abstract = "While anemia is associated with poor functional and mortality outcomes in the elderly, the impact of hemoglobin decline is less studied. We evaluated the determinants and consequences of hemoglobin decline in 3,758 non-anemic participants from the Cardiovascular Health Study, a prospective cohort of community-dwelling elderly ≥65 years old at baseline and followed for up to 16 years. Hemoglobin was measured at baseline and 3 years later and anemia defined by World Health Organization (WHO) criteria. We modeled hemoglobin decline in two ways: (1) per each 1 g/dL decrease in hemoglobin and (2) development of anemia by the WHO criteria. Among participants without baseline anemia, hemoglobin decreased by 0.4 g/dL and 9{\%} developed anemia over 3 years. Baseline increasing age, female sex, diabetes, and kidney disease predicted hemoglobin decline over 3 years. Baseline increasing age, being African-American, and kidney disease predicted anemia development over 3 years. Hemoglobin decline was associated with subsequent worse cognitive function in men and anemia development with subsequent worse cognitive function in women. Both anemia development (HR 1.39, 95{\%} CI 1.15, 1.69) and hemoglobin decline (HR 1.11, 95{\%} CI 1.04, 1.18 per 1 g/dL decrease) predicted subsequent mortality in men and women. Hemoglobin decreases identified a large group of elderly individuals at risk for subsequent adverse outcomes who would not be identified using the WHO anemia criteria. These data may allow clinicians to identify at-risk elderly individuals for early intervention to improve the quality and quantity of life.",
author = "Zakai, {Neil A.} and Benjamin French and Arnold, {Alice M.} and Newman, {Anne B.} and Fried, {Linda F.} and John Robbins and Paulo Chaves and Mary Cushman",
year = "2013",
month = "1",
doi = "10.1002/ajh.23336",
language = "English (US)",
volume = "88",
pages = "5--9",
journal = "American Journal of Hematology",
issn = "0361-8609",
publisher = "Wiley-Liss Inc.",
number = "1",

}

TY - JOUR

T1 - Hemoglobin decline, function, and mortality in the elderly

T2 - The cardiovascular health study

AU - Zakai, Neil A.

AU - French, Benjamin

AU - Arnold, Alice M.

AU - Newman, Anne B.

AU - Fried, Linda F.

AU - Robbins, John

AU - Chaves, Paulo

AU - Cushman, Mary

PY - 2013/1

Y1 - 2013/1

N2 - While anemia is associated with poor functional and mortality outcomes in the elderly, the impact of hemoglobin decline is less studied. We evaluated the determinants and consequences of hemoglobin decline in 3,758 non-anemic participants from the Cardiovascular Health Study, a prospective cohort of community-dwelling elderly ≥65 years old at baseline and followed for up to 16 years. Hemoglobin was measured at baseline and 3 years later and anemia defined by World Health Organization (WHO) criteria. We modeled hemoglobin decline in two ways: (1) per each 1 g/dL decrease in hemoglobin and (2) development of anemia by the WHO criteria. Among participants without baseline anemia, hemoglobin decreased by 0.4 g/dL and 9% developed anemia over 3 years. Baseline increasing age, female sex, diabetes, and kidney disease predicted hemoglobin decline over 3 years. Baseline increasing age, being African-American, and kidney disease predicted anemia development over 3 years. Hemoglobin decline was associated with subsequent worse cognitive function in men and anemia development with subsequent worse cognitive function in women. Both anemia development (HR 1.39, 95% CI 1.15, 1.69) and hemoglobin decline (HR 1.11, 95% CI 1.04, 1.18 per 1 g/dL decrease) predicted subsequent mortality in men and women. Hemoglobin decreases identified a large group of elderly individuals at risk for subsequent adverse outcomes who would not be identified using the WHO anemia criteria. These data may allow clinicians to identify at-risk elderly individuals for early intervention to improve the quality and quantity of life.

AB - While anemia is associated with poor functional and mortality outcomes in the elderly, the impact of hemoglobin decline is less studied. We evaluated the determinants and consequences of hemoglobin decline in 3,758 non-anemic participants from the Cardiovascular Health Study, a prospective cohort of community-dwelling elderly ≥65 years old at baseline and followed for up to 16 years. Hemoglobin was measured at baseline and 3 years later and anemia defined by World Health Organization (WHO) criteria. We modeled hemoglobin decline in two ways: (1) per each 1 g/dL decrease in hemoglobin and (2) development of anemia by the WHO criteria. Among participants without baseline anemia, hemoglobin decreased by 0.4 g/dL and 9% developed anemia over 3 years. Baseline increasing age, female sex, diabetes, and kidney disease predicted hemoglobin decline over 3 years. Baseline increasing age, being African-American, and kidney disease predicted anemia development over 3 years. Hemoglobin decline was associated with subsequent worse cognitive function in men and anemia development with subsequent worse cognitive function in women. Both anemia development (HR 1.39, 95% CI 1.15, 1.69) and hemoglobin decline (HR 1.11, 95% CI 1.04, 1.18 per 1 g/dL decrease) predicted subsequent mortality in men and women. Hemoglobin decreases identified a large group of elderly individuals at risk for subsequent adverse outcomes who would not be identified using the WHO anemia criteria. These data may allow clinicians to identify at-risk elderly individuals for early intervention to improve the quality and quantity of life.

UR - http://www.scopus.com/inward/record.url?scp=84871421287&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84871421287&partnerID=8YFLogxK

U2 - 10.1002/ajh.23336

DO - 10.1002/ajh.23336

M3 - Article

VL - 88

SP - 5

EP - 9

JO - American Journal of Hematology

JF - American Journal of Hematology

SN - 0361-8609

IS - 1

ER -